Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Diabetologia
; 52(11): 2328-2336, 2009 Nov.
Article
in En
| MEDLINE
| ID: mdl-19688336
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cognition
/
Perindopril
/
Diabetes Mellitus, Type 2
/
Diabetic Angiopathies
/
Gliclazide
/
Hypoglycemia
/
Indapamide
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Diabetologia
Year:
2009
Document type:
Article
Affiliation country:
Country of publication: